MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

partnership deal..., page-2

  1. 865 Posts.
    this company isnt what you call a dog,share price is realistic at current levels-when it went to $2.50c -it was on hype-usually most biotechs will recieve just before a announcement.
    However now the company has another potental drug that could be anything as well-which makes the company a far better company due to having the risk of failing split in two-However if the company does get a partner it would be a big boost,more than doubling the share price-expect around the $2-$1.50c mark-but if the company is that good why doesnt yhe company buy out the company completely-if that is the case i suggest a price of about $3.50c/dream on
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.